Benzinga's Volume Movers

Adamas Pharmaceuticals Inc ADMS shares rose 54.63 percent to $26.07. The volume of Adamas Pharmaceuticals shares traded was 4707 percent higher than normal. Adamas Pharmaceuticals reported positive top line Phase 3 results for ADS-5102. Rewalk Robotics Ltd RWLK surged 10.58 percent to $15.89. The volume of Rewalk Robotics shares traded was 466 percent higher than normal. Rewalk Robotics shares have dropped 33.66 percent over the past 52 weeks, while the S&P 500 index has declined 2.06 percent in the same period. Rovi Corporation ROVI shares moved up 35.24 percent to $15.35. The volume of Rovi traded was 453 percent higher than normal. Rovi and AT&T Inc. T reported a deal for seven-year renewal and expansion of license agreement. Celgene Corporation CELG shares climbed 7.21 percent to $119.15. The volume of Celgene shares traded was 284 percent higher than normal. Celgene has settled its REVLIMID patent litigation.